| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bausch Health Companies Inc. (BHC) has 13 insiders with recent SEC Form 4 filings, including 9 buys and 2 sells. BHC is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 73.26M | $342.10M | - | |
| CEO | 2.92M | $13.64M | - | |
| VP | 637.5K | $2.98M | - | |
| Dir | 360.1K | $1.68M | - | |
| Dir | 282.2K | $1.32M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 15, 2018 | De Schutter Richard U | Director | Buy | 15,000 | $21.83 | $327,450.00 | +12.7% | |
| Mar 13, 2018 | Herendeen Paul | EVP And CFO | Buy | 15,000 | $16.10 | $241,470.00 | +6.9% | |
| Mar 13, 2018 | Papa Joseph C | Chairman &CEO | Buy | 30,000 | $16.05 | $481,500.00 | +4.4% | |
| Mar 8, 2018 | De Schutter Richard U | Director | Buy | 10,000 | $15.34 | $153,400.00 | +10.4% | |
| Mar 6, 2018 | Paulson John52 | Director | Sell | 7,066,629 | $15.40 | $108,826,086.60 | -33.9% | |
| Mar 6, 2018 | Paulson John52 | Director | Buy | 7,066,629 | $15.40 | $108,826,086.60 | +51.3% | |
| Nov 17, 2017 | De Schutter Richard U | Director | Buy | 10,000 | $14.33 | $143,300.00 | +11.8% | |
| Nov 16, 2017 | Paulson John52 | Director | Sell | 344,216 | $14.39 | $4,952,820.76 | -1.6% | |
| Nov 16, 2017 | Paulson John52 | Director | Buy | 344,216 | $14.40 | $4,955,505.64 | +1.7% | |
| Aug 21, 2017 | De Schutter Richard U | Director | Buy | 10,000 | $14.33 | $143,296.00 | +6.7% |